COVID-19 Vaccine Booster Dose Willingness Among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study

Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli
doi: https://doi.org/10.1101/2022.07.18.22277757

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted July 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email
COVID-19 Vaccine Booster Dose Willingness Among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli
medRxiv 2022.07.18.22277757; doi: https://doi.org/10.1101/2022.07.18.22277757
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area